Citigroup
CMTA

Citigroup’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Citigroup’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-43,349
Closed -$1.13M – 7968
2019
Q1 		$1.13M Buy
+43,349
New +$810K ﹤0.01% 3265

Citigroup's CMTA Position: Q2 2019 in Review

Citigroup sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 43,349 shares — an estimated $1.13M sold.

Citigroup first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $1.13M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Citigroup reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Citigroup sold 43,349 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $1.13M.
  • Citigroup first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Citigroup's Clementia Pharmaceuticals Inc. position peaked at $1.13M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Citigroup's 13F filing for Q2 2019, filed 12 Aug 2019.